Elevai Non Current Assets Total vs Cash And Short Term Investments Analysis
| ELAB Stock | 0.02 0 20.90% |
Elevai Labs, financial indicator trend analysis is much more than just examining Elevai Labs, Common latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Elevai Labs, Common is a good investment. Please check the relationship between Elevai Labs, Non Current Assets Total and its Cash And Short Term Investments accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevai Labs, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Non Current Assets Total vs Cash And Short Term Investments
Non Current Assets Total vs Cash And Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Elevai Labs, Common Non Current Assets Total account and Cash And Short Term Investments. At this time, the significance of the direction appears to have strong relationship.
The correlation between Elevai Labs,'s Non Current Assets Total and Cash And Short Term Investments is 0.78. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Elevai Labs, Common, assuming nothing else is changed. The correlation between historical values of Elevai Labs,'s Non Current Assets Total and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Elevai Labs, Common are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Non Current Assets Total i.e., Elevai Labs,'s Non Current Assets Total and Cash And Short Term Investments go up and down completely randomly.
Correlation Coefficient | 0.78 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Elevai Labs, Common balance sheet. This account contains Elevai Labs, investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Elevai Labs, Common fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Most indicators from Elevai Labs,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Elevai Labs, Common current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevai Labs, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Elevai Labs,'s Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 16.8 M, whereas Issuance Of Capital Stock is forecasted to decline to about 3.9 M.
| 2010 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 2.8K | 6.5K | 11.6K | 7.7K | Cost Of Revenue | 2.8K | 324.0K | 578.0K | 331.8K |
Elevai Labs, fundamental ratios Correlations
Click cells to compare fundamentals
Elevai Labs, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Elevai Labs, Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elevai Labs,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elevai Labs, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elevai Labs, Common Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevai Labs, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs,. If investors know Elevai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevai Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.44) | Revenue Per Share 0.168 | Quarterly Revenue Growth 0.913 | Return On Assets (0.89) | Return On Equity (3.51) |
The market value of Elevai Labs, Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs,'s value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs,'s market value can be influenced by many factors that don't directly affect Elevai Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevai Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevai Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevai Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.